Clinical Trials Directory

Trials / Completed

CompletedNCT01160185

Meta-analysis of Efficacy of Topotecan

Meta-analysis of Efficacy of Topotecan and Other Treatments for Recurrent Carcinoma of the Cervix

Status
Completed
Phase
—
Study type
Observational
Enrollment
1 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

This meta-analysis was conducted to investigate the efficacy of Topotecan and other treatments for recurrent and stage IVB carcinoma of the cervix

Detailed description

Studies included in the meta-analysis were: GOG-0179, GOG-0204 \& GOG-0169

Conditions

Interventions

TypeNameDescription
DRUGpaclitaxelpaclitacel
DRUGcisplatincisplatin monotherapy
DRUGtopotecantopotecan

Timeline

Start date
2009-06-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2010-07-12
Last updated
2010-07-12

Source: ClinicalTrials.gov record NCT01160185. Inclusion in this directory is not an endorsement.

Meta-analysis of Efficacy of Topotecan (NCT01160185) · Clinical Trials Directory